Hossein Ardeschir Ghofrani
Justus-Liebig-Universität Giessen
H-index: 117
Europe-Germany
Top articles of Hossein Ardeschir Ghofrani
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Unravelling susceptibility to COPD: insights from a novel in vitro model to potential therapeutic targets | C Wu A Cilic K Lo H Watz F Pedersen | 2024/3/15 | |
The Effect of Mitotempo Treatment on HIF-1α Stabilization and Hypoxia-induced Pulmonary Hypertension in Mice | C Nardiello E Zeidan A Sydykov M Brossien A Taye | 2024/5 | |
Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension | The Journal of Heart and Lung Transplantation | Zvonimir A Rako Athiththan Yogeswaran Selin Yildiz Peter Weidemann Daniel Zedler | 2024/2/17 |
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era | Circulation | Felix Gerhardt Eva Fiessler Karen M Olsson Moritz Z Kayser Gabor Kovacs | 2024/4/12 |
A Simple and Safe Method for Checking the Position of Central Venous Catheters—A New and Reliable Threshold for Right Atrial Swirl Sign in Microbubbles Tests | Journal of Clinical Medicine | Lukas Ley Hossein Ardeschir Ghofrani Pascal Klingenberger Tilo Niemann Jens Allendörfer | 2024/3/14 |
uniPHied: A Novel Platform Study Design for a Phase 2 Clinical Trial to Assess the Safety and Efficacy of AER-901 in Pulmonary Hypertension Associated With Interstitial Lung … | VV Mclaughlin HA Ghofrani OA Shlobin S Rajagopal M Hoeper | 2024/5 | |
Kommentar zu den Leitlinien (2022) der ESC/ERS zur Diagnostik und Behandlung der pulmonalen Hypertonie | Stephan Rosenkranz Stefan Frantz Daniel Dumitrescu Christina A Eichstaedt H Ardeschir Ghofrani | 2024/2 | |
Consistency of the Efficacy and Safety Profile of Sotatercept across Baseline Cardiac Index Subgroups: A Pooled Analysis of STELLAR and PULSAR Trials | The Journal of Heart and Lung Transplantation | M Gomberg-Maitland DB Badesch JR Gibbs E Grunig MM Hoeper | 2024/4/1 |
Physiological Mechanisms Behind Respiratory-induced Variations in Right Atrial Pressure | A Yogeswaran B Brito Da Rocha D Zedler Z Rako HA Ghofrani | 2024/5 | |
Einfluss einer PH-spezifischen Therapie auf die Belastungsfähigkeit und Mortalität von Patienten mit präkapillärer pulmonaler Hypertonie mit mPAP zwischen 21-24 mmHg | Pneumologie | A Yogeswaran B da Rocha Brito Z Rako D Zedler H Ghofrani | 2024/3 |
Evaluation of troponin I serum levels in patients with arrhythmias with and without coronary artery disease | Medizinische Klinik-Intensivmedizin und Notfallmedizin | Dirk Bandorski Reinhard Höltgen Marcus Wieczorek Hossein Ardeschir Ghofrani Harilaos Bogossian | 2024/2 |
Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH) | The Journal of Heart and Lung Transplantation | RL Benza R Osterhout S Hoffman RT Zamanian AR Hemnes | 2024/4/1 |
Interim Results From the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH) | O Sitbon S Sahay P Escribano Subías RL Zolty JF Kingrey | 2024/5 | |
Detektion der diastolischen Steifigkeit des rechten Ventrikels: Ein Ansatz für das Patientenbett. | Pneumologie | B da Rocha Brito N Kremer Z Rako H Gall H Ghofrani | 2024/3 |
The Role of CEACAM6/HO-1 Axis in a Mouse Model of Cigarette Smoke-induced Lung Injury | C-Y Wu H Treis A Cilic K Lo N Sommer | 2024/5 | |
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis | Rheumatology | Oliver Distler Christian Ofner Dörte Huscher Suzana Jordan Silvia Ulrich | 2024/4/1 |
Non-invasiv quantifiziertes RV-PA Coupling als unabhängiger Prädiktor für das Überleben beim NSCLC | Pneumologie | Z Rako M Cekay S Yildiz C Mummert J Franken | 2024/3 |
Prognostic Value of the Multicomponent Improvement (MCI) Endpoint in Patients With Pulmonary Arterial Hypertension (PAH) Treated With Sotatercept | AB Waxman DB Badesch JSR Gibbs HA Ghofrani M Gomberg-Maitland | 2024/5 | |
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo … | The Lancet Respiratory Medicine | Hossein-Ardeschir Ghofrani Gérald Simonneau Andrea M D'Armini Peter Fedullo Luke S Howard | 2024/4/1 |
Pulmonal-vaskulärer Phänotyp bei Patienten mit pulmonaler arterieller Hypertonie und Ko-Morbiditäten | Pneumologie | M Richter A Yogeswaran H Gall H Ghofrani S Yildiz | 2024/3 |
Co-Authors
